News
PODD
164.73
-0.92%
-1.53
ICON (ICLR) Gains From New Offerings, Strategic Acquisitions
NASDAQ · 1d ago
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
NASDAQ · 1d ago
Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
NASDAQ · 2d ago
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
NASDAQ · 2d ago
ClearBridge Multi Cap Growth Strategy Q1 2024 Portfolio Manager Commentary
ClearBridge Multi Cap Growth Strategy Q1 2024 Portfolio Manager Commentary. The positive momentum of 2023 extended into the first quarter. Growth stocks maintained their advantage over value stocks in a historically concentrated market. The Russell 3000 Growth Index has become a less relevant measure of ClearBridge's performance.
Seeking Alpha · 2d ago
Here's Why You Should Retain Henry Schein (HSIC) Stock for Now
NASDAQ · 2d ago
ClearBridge Select Strategy Q1 2024 Portfolio Manager Commentary
ClearBridge Select Strategy Q1 2024. The positive momentum of 2023 extended into the first quarter. The S&P 500 Index advanced 10.56% and the Russell 3000 Index gained 10.02%. Growth stocks topped value across most market caps. Stronger than expected growth in retail, financials and industrials.
Seeking Alpha · 2d ago
Labcorp (LH) to Report Q1 Earnings: What's in the Cards?
NASDAQ · 3d ago
7 Stable Stocks for 50% Returns by Early 2025
NASDAQ · 4d ago
Weekly Report: what happened at PODD last week (0408-0412)?
Weekly Report · 4d ago
Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors
Insulet Corporation (NASDAQ:PODD) has a price-to-sales ratio of 7.2x. The Medical Equipment company is trading at a high price to sales ratio compared to the industry. Insulet's revenues have been rising faster than most other companies. The company's P/S is high on the merit of its strong future revenues. The next three years should generate growth of 17% per year.
Simply Wall St · 5d ago
Wall Street Breakfast: What Moved Markets
The S&P 500 posted its worst weekly performance since October 2023 this week. The benchmark index fell nearly 2% from Monday through Friday. The latest consumer price index report reinforced hawkish expectations for the Federal Reserve. Geopolitical tensions in the Middle East and the start of the first quarter earnings season grabbed headlines.
Seeking Alpha · 6d ago
ClearBridge Aggressive Growth Strategy Q1 2024 Portfolio Manager Commentary
ClearBridge Aggressive Growth Strategy Q1 2024 Portfolio Manager Commentary. The positive momentum of 2023 extended into the first quarter. The S&P 500 Index advanced 10.56% for its best start since 2019. Despite the growing chorus for a soft landing, equities still face an uncertain macro backdrop.
Seeking Alpha · 04/12 11:20
Insulet (PODD) Stock Moves -0.34%: What You Should Know
NASDAQ · 04/10 22:15
New additions to Goldman’s High Operating Leverage list
New additions to Goldman’s High Operating Leverage list. Goldman Sachs rebalanced its list of high operating leverage stocks. High operating leverage companies generate more sales without increasing their costs. These stocks have historically performed best when the ISM Manufacturing index is in expansion territory.
Seeking Alpha · 04/10 15:58
Neogen (NEOG) Q3 Earnings Miss Estimates, Gross Margin Expands
NASDAQ · 04/10 12:06
BUZZ-U.S. STOCKS ON THE MOVE-Digital Realty, Alphabet, Moderna
Dow Jones Industrial Average was down 0.52% on Tuesday. Wall Street's main stock indexes gained on Tuesday supported by retreating Treasury yields. Investors await a key inflation print later in the week that could help shape the Fed's stance on interest-rate cuts. Digital Realty, Alphabet, Moderna are among the day's top stocks.
Reuters · 04/09 16:20
Citi’s value focus list of small and mid-caps
Citi’s value focus list of small and mid-caps. The Russell 2500 was up 3.7% year-to-date through April 4, after yielding 17.4% in 2023. The Value Creators List Index Weight is up 7.5%.
Seeking Alpha · 04/08 13:07
SPY ETF Update, 4/8/2024 
TipRanks · 04/08 10:29
Weekly Report: what happened at PODD last week (0401-0405)?
Weekly Report · 04/08 09:04
More
Webull provides a variety of real-time PODD stock news. You can receive the latest news about Insulet Corp through multiple platforms. This information may help you make smarter investment decisions.
About PODD
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.